ATA95989A - Pyridoncarbonsäurederivate und salze hievon, verfahren zur herstellung derselben und antibakterielle mittel, welche diese enthalten - Google Patents

Pyridoncarbonsäurederivate und salze hievon, verfahren zur herstellung derselben und antibakterielle mittel, welche diese enthalten

Info

Publication number
ATA95989A
ATA95989A AT0095989A AT95989A ATA95989A AT A95989 A ATA95989 A AT A95989A AT 0095989 A AT0095989 A AT 0095989A AT 95989 A AT95989 A AT 95989A AT A95989 A ATA95989 A AT A95989A
Authority
AT
Austria
Prior art keywords
pyridone
salts
contain
producing
same
Prior art date
Application number
AT0095989A
Other languages
English (en)
Other versions
AT398422B (de
Original Assignee
Toyama Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toyama Chemical Co Ltd filed Critical Toyama Chemical Co Ltd
Publication of ATA95989A publication Critical patent/ATA95989A/de
Application granted granted Critical
Publication of AT398422B publication Critical patent/AT398422B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/06—Peri-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/06—Peri-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/06—Peri-condensed systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
AT0095989A 1988-04-23 1989-04-21 Pyridoncarbonsäurederivate und salze hievon, verfahren zur herstellung derselben und antibakterielle mittel, welche diese enthalten AT398422B (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP10062888 1988-04-23
JP1075873A JPH0228178A (ja) 1988-04-23 1989-03-28 新規なピリドンカルボン酸誘導体およびその塩並びにそれらの製造法

Publications (2)

Publication Number Publication Date
ATA95989A true ATA95989A (de) 1994-04-15
AT398422B AT398422B (de) 1994-12-27

Family

ID=26417038

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0095989A AT398422B (de) 1988-04-23 1989-04-21 Pyridoncarbonsäurederivate und salze hievon, verfahren zur herstellung derselben und antibakterielle mittel, welche diese enthalten

Country Status (21)

Country Link
US (1) US4990508A (de)
JP (1) JPH0228178A (de)
KR (1) KR910005833B1 (de)
AT (1) AT398422B (de)
AU (1) AU601324B2 (de)
BE (1) BE1003252A4 (de)
CA (1) CA1340493C (de)
CH (1) CH680793A5 (de)
DE (1) DE3913245C2 (de)
DK (1) DK175649B1 (de)
ES (1) ES2016012A6 (de)
FI (1) FI91529C (de)
FR (1) FR2630441B1 (de)
GB (1) GB2217710B (de)
HU (2) HU205759B (de)
IL (1) IL89931A (de)
IT (1) IT1231760B (de)
NL (1) NL192832C (de)
NO (1) NO171214C (de)
NZ (1) NZ228847A (de)
SE (1) SE504625C2 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5104868A (en) * 1988-06-21 1992-04-14 Pfizer Inc. Tricyclic derivatives of 7-substituted-6-fluoro-1,4-dihydroquinol-4-one-3-carboxylic acids and esters
EP0997466A1 (de) * 1988-10-24 2000-05-03 PROCTER & GAMBLE PHARMACEUTICALS, INC. Antimikrobielle Laktamchinolone
EP0449445A3 (en) * 1990-03-27 1993-08-25 Pfizer Inc. Preparation of beta-ketoesters useful in preparing quinolone antibiotics
IT1248011B (it) * 1991-06-07 1995-01-05 Mediolanum Farmaceutici Spa Procedimento per la preparazione dell'acido 9-fluoro-10- (4-metil-1-piperazinil)-7-oxo-2,3-diidro-7h-pirido (1,2,3-de) (1,4)benzotiadin-6-carbossilico cloridrato.
EG20543A (en) * 1992-10-30 1999-07-31 Procter & Gamble Process for preparing of novel antimicrobial -5- (n-heterosubstituted amino) quinolones
TW252107B (de) * 1993-08-27 1995-07-21 Hokuriku Pharmacetical Co Ltd
IT1270834B (it) * 1993-10-27 1997-05-13 Archimica Spa Disolfuro chinolico
IT1270836B (it) * 1993-10-27 1997-05-13 Archimica Spa Procedimento per la preparazione di rufloxacina e suoi sali
USH1480H (en) * 1993-12-09 1995-09-05 The Procter & Gamble Company Methods of using dyphylline for the promotion of hair growth
AU3192700A (en) 1999-03-17 2000-10-04 Daiichi Pharmaceutical Co., Ltd. Medicinal compositions
AP2004003143A0 (en) * 2002-03-21 2004-09-30 Basf Ag Fungicidal triazolopyrimidines, methods for producing the same, use thereof for combating harmful fungi and agents containing said substances.
CN1332962C (zh) * 2005-07-12 2007-08-22 武汉人福药业有限责任公司 一种合成甲磺酸帕珠沙星中间体的方法
KR101419554B1 (ko) * 2006-03-13 2014-07-17 교린 세이야꾸 가부시키 가이샤 Ｇｓｋ­３ 억제제로서 아미노퀴놀론
BRPI0816798A2 (pt) * 2007-09-11 2016-10-11 Activx Biosciences Inc composto, composição farmacêutica, métodos para inibir a ação do glicogênio sintase cinase-3, e para tratar, prevenir ou melhorar uma doença, uso de um composto, e, artigo de fabricação
CN101855229A (zh) 2007-09-12 2010-10-06 埃迪威克斯生物科学公司 作为gsk-3抑制剂的螺环状氨基喹诺酮
BRPI1008974A2 (pt) * 2009-03-11 2017-06-06 Kyorin Seiyaku Kk composto, composição farmacêutica, e, método para tratar, prevenir ou melhorar uma doença mediada com gsk-3
CN101928290B (zh) * 2009-11-27 2011-11-09 浙江司太立制药股份有限公司 一种甲磺酸帕珠沙星的纯化方法
CN102295652A (zh) * 2011-06-27 2011-12-28 辽宁海神联盛制药有限公司 一种甲磺酸帕珠沙星合成工艺的改进方法
CN102850375A (zh) * 2012-03-06 2013-01-02 江西师范大学 一类多取代吡啶并[4, 3-d]噁嗪化合物及制备方法
CN103772412B (zh) * 2012-10-23 2016-03-16 浙江海森药业有限公司 一种帕珠沙星中间体的制备方法
CN105622632B (zh) * 2014-10-29 2018-06-29 浙江海森药业股份有限公司 一种喹诺酮类化合物及其制备方法

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3883522A (en) * 1974-02-11 1975-05-13 Riker Laboratories Inc Substituted pyrido(1,2,3-de)-1,4-benzoxazines
DE3211984C2 (de) * 1981-05-21 1986-04-03 Dieter Dr. 7900 Ulm Benz Rotierende Zahnbürste
JPS591489A (ja) * 1982-06-29 1984-01-06 Dai Ichi Seiyaku Co Ltd ピリドベンゾオキサジン誘導体
DE3234529A1 (de) * 1982-09-17 1984-03-22 Bayer Ag, 5090 Leverkusen Substituierte benzoxazin-derivate
US4603199A (en) * 1982-10-25 1986-07-29 Riker Laboratories, Inc. Phenyl-substituted tricyclic antibacterial agent intermediates
US4607032A (en) * 1984-04-26 1986-08-19 Abbott Laboratories Quino-benoxazine antibacterial compounds
US4540694A (en) * 1984-04-26 1985-09-10 Abbott Laboratories 1-Pyridine substituted quino-benoxazines and antibacterial use
US4822801A (en) * 1984-07-20 1989-04-18 Warner-Lambert Company 4-oxo-1,4-dihydroquinoline-3-carboxylic acid derivative as antibacterial agents
US4623650A (en) * 1984-12-06 1986-11-18 Pfizer Inc. Antibiotic derivatives of 7-phenyl-1,4-dihydro-4-oxo-3-quinolinecarboxylic acids
DE3517709A1 (de) * 1985-01-05 1986-07-10 Bayer Ag Basische zubereitungen von chinoloncarbonsaeuren
DE3525108A1 (de) * 1985-06-07 1986-12-11 Bayer Ag, 5090 Leverkusen Antibakteriell wirksame chinoloncarbonsaeureester
DE3522406A1 (de) * 1985-06-22 1987-01-02 Bayer Ag Verfahren zur herstellung von 1,8-verbrueckten 4-chinolon-3-carbonsaeuren
DE3522405A1 (de) * 1985-06-22 1987-01-02 Bayer Ag 1,8-verbrueckte 4-chinolon-3-carbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende arzneimittel und ihre verwendung zur herstellung von arzneimitteln
DE3543513A1 (de) * 1985-12-10 1987-06-11 Bayer Ag Enantiomerenreine 1,8-verbrueckte 4-chinolon-3-carbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende arzneimittel und ihre verwendung zur herstellung von arzneimitteln
DE3601567A1 (de) * 1986-01-21 1987-07-23 Bayer Ag 7-(azabicycloalkyl)-chinoloncarbonsaeure- und -naphthyridon-carbonsaeure-derivate
US4777253A (en) * 1986-04-25 1988-10-11 Abbott Laboratories Process for preparation of racemate and optically active ofloxacin and related derivatives
IT1196429B (it) * 1986-07-01 1988-11-16 Mediolanum Farmaceutici Srl Processo per la preparazione di pirido benzotiazine ad attivita' antibatterica e loro sali con acidi solfonici
DE3623757A1 (de) * 1986-07-15 1988-01-21 Bayer Ag Neue 1,8-verbrueckte 4-chinoloncarbonsaeuren und diese enthaltende arzneimittel
DE3639465A1 (de) * 1986-11-18 1988-05-19 Hoechst Ag Optisch aktive gyrasehemmer, ihre herstellung und verwendung als antibiotika
DE3641661A1 (de) * 1986-12-05 1988-06-30 Bayer Ag Verfahren zur herstellung von chinoloncarbonsaeureestern
DE3711193A1 (de) * 1987-04-02 1988-10-13 Bayer Ag 5-substituierte chinolon- und naphthyridoncarbonsaeure-derivate
JP2598921B2 (ja) * 1987-10-05 1997-04-09 富山化学工業株式会社 新規なキノリン誘導体およびその塩
DE3810080A1 (de) * 1988-03-25 1989-10-05 Bayer Ag Trisubstituierte 1,3,5-triazin-2,4,6-trione
DE3815481A1 (de) * 1988-05-06 1989-11-16 Sandoz Ag Sulfonsaeuregruppenfreie basische verbindung
US5039682A (en) * 1988-06-21 1991-08-13 Pfizer Inc. 6-fluoro-1,4-dihydroquinol-4-one-3-carboxylic acid derivatives and intermediates therefor

Also Published As

Publication number Publication date
US4990508A (en) 1991-02-05
FR2630441B1 (fr) 1994-10-14
GB2217710B (en) 1991-12-04
ES2016012A6 (es) 1990-10-01
HU205759B (en) 1992-06-29
NO891650D0 (no) 1989-04-21
NL192832C (nl) 1998-03-04
GB2217710A (en) 1989-11-01
IT1231760B (it) 1991-12-21
DE3913245A1 (de) 1989-11-02
FI91529B (fi) 1994-03-31
FI891910A0 (fi) 1989-04-21
NO891650L (no) 1989-10-24
DK175649B1 (da) 2005-01-03
DK192589D0 (da) 1989-04-20
IL89931A0 (en) 1989-12-15
NL8901007A (nl) 1989-11-16
SE504625C2 (sv) 1997-03-17
CA1340493C (en) 1999-04-13
SE8901464L (sv) 1989-10-24
FR2630441A1 (fr) 1989-10-27
AT398422B (de) 1994-12-27
FI91529C (fi) 1994-07-11
BE1003252A4 (fr) 1992-02-11
AU3266189A (en) 1989-10-26
JPH0588714B2 (de) 1993-12-24
CH680793A5 (de) 1992-11-13
HUT51621A (en) 1990-05-28
JPH0228178A (ja) 1990-01-30
HU211568A9 (en) 1995-12-28
FI891910A7 (fi) 1989-10-24
NO171214B (no) 1992-11-02
NL192832B (nl) 1997-11-03
KR900016222A (ko) 1990-11-12
NZ228847A (en) 1990-04-26
KR910005833B1 (ko) 1991-08-05
GB8908096D0 (en) 1989-05-24
IT8947875A0 (it) 1989-04-21
SE8901464D0 (sv) 1989-04-21
AU601324B2 (en) 1990-09-06
IL89931A (en) 1993-06-10
NO171214C (no) 1993-02-10
DK192589A (da) 1989-10-24
DE3913245C2 (de) 1999-07-15

Similar Documents

Publication Publication Date Title
ATA95989A (de) Pyridoncarbonsäurederivate und salze hievon, verfahren zur herstellung derselben und antibakterielle mittel, welche diese enthalten
DE3579891D1 (de) N-((4,6-dimethoxypyrimidin-2-yl)aminocarbonyl)-3-trifluoromethylpyridin-2-sulfonamide oder salze davon, diese enthaltendes herbizides mittel und verfahren zur herstellung dieser verbindung.
DE68907876D1 (de) Substanz dc 113 und verfahren zu ihrer herstellung.
DE3587725D1 (de) Zahnpflegemittel, Vorrichtung und Verfahren zur Lagerung und Verabreichung desselben.
DE3584463D1 (de) Substituierte naphthyridin-, chinolin- und benzoxazin-carbonsaeuren als bakterizide mittel und verfahren zu ihrer herstellung.
DE68919650D1 (de) 3'-Hydroxysubstituiertes Benzoxazinorifamycinderivat, Verfahren zu seiner Herstellung und dieses enthaltendes antibakterielles Mittel.
ATA243992A (de) Verfahren zur herstellung von zur selektiven senkung des blutlipoidspiegels geeigneten arzneimittelpräparaten
ATA122485A (de) Verfahren zur herstellung von neuen 1,4-dihydro-4-oxonaphthyridin-derivaten und deren salzen
DE3777931D1 (de) Titandioxydsol und verfahren zur seiner herstellung.
DE3787586D1 (de) Alkylsubstituiertes benzoxazinorifamycinderivat, verfahren zu seiner herstellung und dieses enthaltendes antibakterielles mittel.
DE3686444D1 (de) N-fluorpyridiniumsalz und verfahren zur herstellung.
ATA247489A (de) Festes pharmazeutisches piroxicam-präparat und verfahren zu seiner herstellung
DE58905246D1 (de) Heterocyclische substituierte alkoxycumarine, verfahren zu ihrer herstellung und diese enthaltende therapeutische mittel.
DE3485386D1 (de) Chemisches verfahren zur herstellung von antibiotikum l 17392 (deglucoteicoplanin) und dessen salzen.
DE3667286D1 (de) Benzoxazinorifamycinderivat, verfahren zu seiner herstellung und diese enthaltende baktericide mittel.
DE3880953D1 (de) Chinolinderivate, verfahren zur herstellung davon und diese enthaltendes antibakterielles mittel.
ATA904485A (de) Hautregenerierendes kosmetisches mittel und verfahren zu seiner herstellung
ATA901686A (de) Kosmetische mittel mit hautberuhigender und hautregenerierender wirkung und verfahren zu deren herstellung
DE68908464D1 (de) Nadelfoermige titandioxydteilchen und verfahren zu ihrer herstellung.
ATA133390A (de) Neue penamderivate und deren salze, verfahren zur herstellung derselben und dieselben enthaltende antibakterielle mittel
DE3886936D1 (de) 2,5,6,7-TETRANOR-4,8-INTER-m-PHENYLEN 2-PGI-DERIVATE, VERFAHREN ZUR HERSTELLUNG UND DEREN VERWENDUNG.
ATA392484A (de) Verfahren zur herstellung von neuen 4,5,6,7tetrahydrothiazolo(5,4-c)pyridinderivaten und deren pharmazeutisch annehmbaren saeureadditionssalzen
DE3674585D1 (de) Zubereitung zur behandlung und vorbeugung von diarrhoee bei menschen und tieren und verfahren zu deren herstellung.
PT91415A (pt) Processo para a preparacao de novos derivados de furiltiazol
ATE136895T1 (de) Imidazolidin-derivate, verfahren zu deren herstellung und diese enthaltende schädlingsbekämpfungsmittel

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee
ELA Expired due to lapse of time